PLYMOUTH MEETING, Pa. (AP) _ Inovio Pharmaceuticals Inc. (INO) on Thursday reported a loss of $29.2 million in its first quarter.
On a per-share basis, the Plymouth Meeting, Pennsylvania-based company said it had a loss of 30 cents.
The results missed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 29 cents per share.
The drugmaker posted revenue of $2.8 million in the period, also falling short of Street forecasts. Three analysts surveyed by Zacks expected $4.4 million.
In the final minutes of trading on Thursday, the company's shares hit $3.87. A year ago, they were trading at $4.83.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on INO at https://www.zacks.com/ap/INO